Newsroom
Sorted by: Latest
-
Securities Fraud Investigation Into JD.com, Inc. (JD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of JD.com, Inc. (“JD” or the “Company”) (NASDAQ: JD) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON JD.COM, INC. (JD), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On June 11, 2026, Bloomb...
-
Securities Fraud Investigation Into Erasca, Inc. (ERAS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Erasca, Inc. (“Erasca” or the “Company”) (NASDAQ: ERAS) investors concerning the Company’s possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON ERASCA, INC. (ERAS), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.What Happened?On April 27, 2026, b...
-
Securities Fraud Investigation Into The Ensign Group, Inc. (ENSG) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of The Ensign Group, Inc. (“Ensign” or the “Company”) (NASDAQ: ENSG) investors concerning the Company’s possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON ENSIGN GROUP, INC. (ENSG), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.What Happened?On June 8, 2026, investment med...
-
Securities Fraud Investigation Into Alibaba Group Holding Ltd. (BABA) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, A Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Alibaba Group Holding Ltd. (“Alibaba” or the “Company”) (NYSE: BABA) investors concerning the Company’s possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON ALIBABA GROUP HOLDING LTD. (BABA), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.What Happened?On November 14, 2024...
-
Securities Fraud Investigation Into PDD Holdings Inc. (PDD) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of PDD Holdings Inc. (“PDD” or the “Company”) (NASDAQ: PDD) investors concerning the Company’s possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON PDD HOLDINGS INC. (PDD), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.What Happened?On January 19, 2026, Bloomberg reported that Chi...
-
Qnity to Present at the Wolfe Research Materials of the Future Conference
WILMINGTON, Del.--(BUSINESS WIRE)--Qnity Electronics, Inc. (“Qnity”) (NYSE: Q), a premier technology solutions leader across the semiconductor value chain, today announced that Jon Kemp, Qnity’s Chief Executive Officer, will participate in a fireside chat at the Wolfe Research 3rd Annual Materials of the Future Conference on June 16, 2026, at 8:35 a.m. ET. A live webcast of the fireside chat will be available at Events | Qnity Electronics, Inc. (Q). A replay of the webcast will be available fol...
-
Samenvatting: IQM benoemt Barbara Venneman, bestuurslid van Vanguard en voormalig internationaal hoofd van Deloitte Digital, tot lid van de Raad van Bestuur
ESPOO, Finland--(BUSINESS WIRE)--IQM Quantum Computers, wereldleider in supergeleidende kwantumcomputers, kondigde vandaag de benoeming aan van Barbara Venneman tot lid van de Raad van Bestuur. Venneman verdiept de expertise van de Raad in digitale transformatie, commercialisering van bedrijfstechnologie en wereldwijde schaalvergroting van het bedrijf nu IQM zijn commerciële voetafdruk over de hele wereld uitbreidt. Verder zal CEO en medeoprichter Jan Goetz medeoprichter Juha Vartiainen vervang...
-
Tanner Health and InStockRx Partner to Ensure Every Medication Dose Reaches a Patient in Need
CARROLLTON, Ga.--(BUSINESS WIRE)--Tanner Health and Healthliant Ventures partner with InStockRx to eliminate medication waste and ensure every dose is used for treating a patient....
-
La PDG de MindWalk (NASDAQ : HYFT), Jennifer Bath, participera à la table ronde organisée par Jones AI Day sur l’avenir de la découverte de médicaments par l’IA, à laquelle partipera Absci (NASDAQ : ABSI), un important fournisseur de services d'IA...
AUSTIN, Texas--(BUSINESS WIRE)-- La PDG de MindWalk (NASDAQ : HYFT), Jennifer Bath, participera à la table ronde organisée par Jones AI Day sur l’avenir de la découverte de médicaments par l’IA, à laquelle partipera Absci (NASDAQ : ABSI), un important fournisseur de services d'IA pour le calcul MindWalk Holdings Corp. (« MindWalk ») (NASDAQ : HYFT), entreprise spécialisée dans l'intelligence artificielle bio-native, a annoncé aujourd'hui que sa PDG, Jennifer Bath, participera à une table ronde...
-
Franquia de hematologia fundamental da BeOne Medicines lidera próxima era da inovação em câncer de células B na EHA 2026
SAN CARLOS, Califórnia--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), uma empresa multinacional de oncologia, anunciou hoje novos dados de sua principal linha de produtos hematológicos no Congresso da Associação Europeia de Hematologia (EHA) de 2026, em Estocolmo. Os resultados atualizados do tacabrutideg (BGB-16673), um potencial degradador de tirosina quinase de Bruton (BTK) líder de mercado, demonstraram respostas duradouras em pacientes com leucemia linfocít...
